Evaluating the Efficacy and Safety of Different Pterygium Surgeries: A Review of the Literature

Overview

Journal Int J Environ Res Public Health

Publisher MDPI

Specialties Environmental Health
Public Health

Date 2022 Sep 23

PMID 36141628

Authors

Marcin Palewski

Agnieszka Budnik

Joanna Konopinska

Affiliations

Soon will be listed here.

Abstract

The search for the "gold standard" in the surgical treatment of pterygium has been ongoing for over two decades. Despite the development of various surgical techniques, recurrence rates range from 6.7% to 88% depending on the method used. This review discusses the latest and most commonly used methods for the surgical removal of pterygium, primarily focusing on efficacy and safety. Moreover, this review includes articles that either evaluated or compared surgical methods and clinical trials for primary and recurrent pterygium. Limited data are available on combined methods as well as on the efficacy of adjuvant treatment. The use of adjuvant intraoperative mitomycin C (MMC) and conjunctival autografting (CAU) are the two most highly recommended options, as they have the lowest rates of postoperative recurrence.

Citing Articles

Inhibition of pterygium cell fibrosis by the Rho kinase inhibitor.

Dai J, Rayana N, Peng M, Sugali C, Harvey D, Dhamodaran K Sci Rep. 2024; 14(1):30930.

PMID: 39730553 PMC: 11680712. DOI: 10.1038/s41598-024-81659-6.

Unravelling the molecular tapestry of pterygium: insights into genes for diagnostic and therapeutic innovations.

Gupta M, Arya S, Agrawal P, Gupta H, Sikka R Eye (Lond). 2024; 38(15):2880-2887.

PMID: 38907016 PMC: 11461965. DOI: 10.1038/s41433-024-03186-y.

Expression of CD44, PCNA and E-cadherin in pterygium tissues.

Yildirim H, Turan G, Turan M Indian J Ophthalmol. 2024; 72(Suppl 3):S501-S504.

PMID: 38648458 PMC: 467005. DOI: 10.4103/IJO.IJO_2579_23.

Ocular-Surface Regeneration Therapies for Eye Disorders: The State of the Art.

Posarelli M, Romano D, Tucci D, Giannaccare G, Scorcia V, Taloni A BioTech (Basel). 2023; 12(2).

PMID: 37366796 PMC: 10295950. DOI: 10.3390/biotech12020048.

References

Kheirkhah A, Nazari R, Safi H, Ghassemi H, Behrouz M, Raju V . Effects of intraoperative steroid injection on the outcome of pterygium surgery. Eye (Lond). 2013; 27(8):906-14. PMC: 3740317. DOI: 10.1038/eye.2013.142. View

Bachelor M, Bowden G . UVA-mediated activation of signaling pathways involved in skin tumor promotion and progression. Semin Cancer Biol. 2004; 14(2):131-8. DOI: 10.1016/j.semcancer.2003.09.017. View

Rao S, Lekha T, Mukesh B, Sitalakshmi G, Padmanabhan P . Conjunctival-limbal autografts for primary and recurrent pterygia: technique and results. Indian J Ophthalmol. 1999; 46(4):203-9. View

Zein H, Ismail A, AbdelMongy M, Elsherif S, Hassanen A, Muhammad B . Autologous Blood for Conjunctival Autograft Fixation in Primary Pterygium Surgery: A Systematic Review and Meta-analysis. Curr Pharm Des. 2018; 24(35):4197-4204. DOI: 10.2174/1381612824666181001161352. View

HILGERS J . Pterygium: its incidence, heredity and etiology. Am J Ophthalmol. 1960; 50:635-44. DOI: 10.1016/0002-9394(60)90245-2. View

McLaren J, Malak T, Bell S . Structural characteristics of term human fetal membranes prior to labour: identification of an area of altered morphology overlying the cervix. Hum Reprod. 1999; 14(1):237-41. DOI: 10.1093/humrep/14.1.237. View

Lotfy A, Gad A, Abdelrahman A, Samir A, Abdulhalim B . Conjunctival Autograft Combined With Either Preoperative Mitomycin C Injection or Intraoperative Local Mitomycin C Over the Medial Rectus Muscle Tendon in Primary Pterygium Surgery. Eye Contact Lens. 2018; 44 Suppl 2:S192-S195. DOI: 10.1097/ICL.0000000000000475. View

Lu P, Chen X, Kang Y, Ke L, Wei X, Zhang W . Pterygium in Tibetans: a population-based study in China. Clin Exp Ophthalmol. 2008; 35(9):828-33. DOI: 10.1111/j.1442-9071.2007.01630.x. View

Murube J . Pterygium: its treatment with beta therapy. Ocul Surf. 2009; 7(1):3-9. DOI: 10.1016/s1542-0124(12)70287-2. View

10.

Sati A, Shankar S, Jha A, Kalra D, Mishra S, Gurunadh V . Comparison of efficacy of three surgical methods of conjunctival autograft fixation in the treatment of pterygium. Int Ophthalmol. 2014; 34(6):1233-9. DOI: 10.1007/s10792-014-0013-y. View

11.

Di Girolamo N, Chui J, Coroneo M, Wakefield D . Pathogenesis of pterygia: role of cytokines, growth factors, and matrix metalloproteinases. Prog Retin Eye Res. 2004; 23(2):195-228. DOI: 10.1016/j.preteyeres.2004.02.002. View

12.

Promesberger J, Kohli S, Busse H, Uhlig C . Pterygium recurrence, astigmatism and visual acuity following bare-sclera excision and conjunctival autograft with or without additional phototherapeutic keratectomy. Ophthalmic Res. 2013; 51(1):52-8. DOI: 10.1159/000355075. View

13.

Murube J . Pterygium: evolution of medical and surgical treatments. Ocul Surf. 2008; 6(4):155-61. DOI: 10.1016/s1542-0124(12)70176-3. View

14.

McCarty C, Fu C, Taylor H . Epidemiology of pterygium in Victoria, Australia. Br J Ophthalmol. 2000; 84(3):289-92. PMC: 1723391. DOI: 10.1136/bjo.84.3.289. View

15.

Rocha G, Yelin J . Meta-analysis on the recurrence rates after bare sclera resection with and without mitomycin C use and conjunctival autograft placement in surgery for primary pterygium. Br J Ophthalmol. 1998; 82(6):661-5. PMC: 1722618. DOI: 10.1136/bjo.82.6.661. View

16.

Dolar Bilge A . Comparison of conjunctival autograft and conjunctival transposition flap techniques in primary pterygium surgery. Saudi J Ophthalmol. 2018; 32(2):110-113. PMC: 6010604. DOI: 10.1016/j.sjopt.2017.11.002. View

17.

Cajucom-Uy H, Tong L, Wong T, Tay W, Saw S . The prevalence of and risk factors for pterygium in an urban Malay population: the Singapore Malay Eye Study (SiMES). Br J Ophthalmol. 2009; 94(8):977-81. DOI: 10.1136/bjo.2008.150847. View

18.

Luthra R, Nemesure B, Wu S, Xie S, Leske M . Frequency and risk factors for pterygium in the Barbados Eye Study. Arch Ophthalmol. 2001; 119(12):1827-32. DOI: 10.1001/archopht.119.12.1827. View

19.

Kasetsuwan N, Reinprayoon U, Satitpitakul V . Prevention of recurrent pterygium with topical bevacizumab 0.05% eye drops: a randomized controlled trial. Clin Ther. 2015; 37(10):2347-51. DOI: 10.1016/j.clinthera.2015.08.023. View

20.

Bekibele C, Ashaye A, Olusanya B, Baiyeroju A, Fasina O, Ibrahim A . 5-Fluorouracil versus mitomycin C as adjuncts to conjunctival autograft in preventing pterygium recurrence. Int Ophthalmol. 2012; 32(1):3-8. DOI: 10.1007/s10792-011-9509-x. View